The following presentations have been added in hopes that it will help other physicians and researchers that are interested in learning more about ECD. The ECDGA is grateful for the efforts and contributions made by the medical community to improve care for ECD patients.

Presenter	Presentation Slides
Ankush Bhatia, MD	Single-agent dabrafenib for BRAFV600E-mutated histiocytosis
Riccardo Biavasco, MD	BRAFV600E expression in hematopoietic progenitors leads to myeloid skewing and histiocytosis
Pascale Chasseur, MD	A cytologic diagnosis of BRAFV600E Erdheim-Chester disease on pericardial fluid
Marina Ferrarini, MD	3-D culture of BRAF and KRAS-mutated Erdheim-Chester disease tissues: impact of kinase inhibitors
Aaron Goodman, MD	Genomics of Erdheim Chester Disease: Implications for Precision Treatment with Targeted Therapy
Gaurav Goyal, MBBS	Efficacy of Biologic Agents in the Treatment of Erdheim-Chester Disease
Gaurav Goyal, MBBS	Increased prevalence of myeloid neoplasms in patients with Erdheim-Chester disease
Julien Haroche, MD, PhD	BRAF V600E mutation is associated with a cardiac and neurological phenotype in Erdheim-Chester disease: results from a 165-patient cohort
Filip Janku, MD, PhD	Clinical molecular profiling of archival tumor tissue and cell-free DNA from patients with Erdheim-Chester disease
Augusto Vaglio, MD	Renal and ureteral involvement in Erdheim-Chester disease: analysis of a single centre cohort

The following photos were taken during the ECD Patient & Family Gathering Reception with medical professionals and ECD families on October 26, 2017 in New York, NY. Thank you to all participants for attending and engaging with the community. Please join us again on November 15, 2018 in Orlando!

The following photos were taken during the ECD Medical Symposium on October 27 in New York, NY. Thank you to all participants and speakers for a fulfilling and enlightening experience at this event. Please join us again on November 15, 2018 in Orlando! Please also see the Patient & Family Gathering page for more.